artículo académico

• Cervicovaginal microbiome and natural history of HPV in a longitudinal study.  PLos Pathogens.  16. 2020
• Durability of Cross-Protection by Different Schedules of the Bivalent HPV Vaccine: The CVT Tria.  Journal of the National Cancer Institute.  112:1030-1037. 2020
• Efficacy of AS04-Adjuvanted Vaccine Against Human Papillomavirus (HPV) Types 16 and 18 in Clearing Incident HPV Infections: Pooled Analysis of Data From the Costa Rica Vaccine Trial and the PATRICIA Study.  Journal of Infectious Diseases.  2020
• Efficacy of the AS04-Adjuvanted HPV16/18 Vaccine: Pooled Analysis of the Costa Rica Vaccine and PATRICIA Randomized Controlled Trials.  Journal of the National Cancer Institute.  112:818-828. 2020
• Evaluation of Durability of a Single Dose of the Bivalent HPV Vaccine: The CVT Trial.  Journal of the National Cancer Institute.  112:1038-1046. 2020
• An Observational Study of Deep Learning and Automated Evaluation of Cervical Images for Cancer Screening.  Journal of the National Cancer Institute.  111:923-932. 2019
• Evaluation of TypeSeq, a Novel High-Throughput, Low-Cost, Next-Generation Sequencing-Based Assay for Detection of 51 Human Papillomavirus Genotypes .  The Journal of Infectious Diseases.  220:1609-1619. 2019
• Classification and evolution of human papillomavirus genome variants: Alpha-5 (HPV26, 51, 69, 82), Alpha-6 (HPV30, 53, 56, 66), Alpha-11 (HPV34, 73), Alpha-13 (HPV54) and Alpha-3 (HPV61).  Virology.  516:86-101. 2018
• Durability of Protection Afforded by Fewer Doses of the HPV16/18 Vaccine: The CVT Trial.  Journal of the National Cancer Institute.  110:205-212. 2018
• Evidence for single-dose protection by the bivalent HPV vaccine—Review of the Costa Rica HPV vaccine trial and future research studies.  Vaccine.  36:4774-4782. 2018
• Niche adaptation and viral transmission of human papillomaviruses from archaic hominins to modern humans.  PLos Pathogens.  14. 2018
• T cell receptor repertoire among women who cleared and failed to clear cervical human papillomavirus infection: An exploratory proof-of-principle study.  PLoS ONE.  13. 2018
• Cervical cancer incidence after screening with HPV, cytology, and visual methods: 18‐Year follow‐up of the Guanacaste cohort.  International Journal of Cancer.  140:1926-1934. 2017
• Impact of human papillomavirus (HPV) 16 and 18 vaccination on prevalent infections and rates of cervical lesions after excisional treatment.  American Journal of Obstetrics and Gynecology.  215:212.e1-212.e15. 2016
• Cross-protection of the Bivalent Human Papillomavirus (HPV) Vaccine Against Variants of Genetically Related High-Risk HPV Infections.  Journal of Infectious Diseases.  213:939-947. 2015
• Effect of bivalent human papillomavirus vaccination on pregnancy outcomes: long term observational follow-up in the Costa Rica HPV Vaccine Trial.  BMJ Journal.  351. 2015
• Multisite HPV16/18 Vaccine Efficacy Against Cervical, Anal, and Oral HPV Infection.  Journal of the National Cancer Institute.  108. 2015
• Performance of Self-Collected Cervical Samples in Screening for Future Precancer Using Human Papillomavirus DNA Testing.  Journal of the National Cancer Institute.  107. 2015
• Rationale and design of a long term follow-up study of women who did and did not receive HPV 16/18 vaccination in Guanacaste, Costa Rica.  Vaccine.  33:2141-2151. 2015
• Alterations of T-cell surface markers in older women with persistent human papillomavirus infection.  International Journal of Cancer.  128:597-607. 2011
• Evolution and taxonomic classification of human papillomavirus 16 (HPV16)-related variant genomes.  PLoS ONE.  6:1-16. 2011
• Behavioral/Lifestyle and Immunologic Factors Associated with HPV Infection among Women Older Than 45 Years.  Cancer Epidemiology Biomarkers & Prevention.  19:3044-3054. 2010
• Elevated Systemic Levels of Inflammatory Cytokines in Older Women with Persistent Cervical Human Papillomavirus Infection.  Cancer Epidemiology Biomarkers & Prevention.  19:1954-1959. 2010
• Persistent Human Papillomavirus Infection Is Associated with a Generalized Decrease in Immune Responsiveness in Older Women.  Cancer Research .  66:11070-11076. 2006